Why Aetna’s pediatric telehealth play with Blueberry could redefine Medicaid access
Can Aetna’s new pediatric telehealth model with Blueberry cut ER visits and scale Medicaid care? Find out what this pilot means for future access.
Can Aetna’s new pediatric telehealth model with Blueberry cut ER visits and scale Medicaid care? Find out what this pilot means for future access.
Alessa's Enolen earns FDA fast track for localized prostate cancer. Find out how this implant could redefine early-stage treatment and challenge current norms.
PharmaJet’s needle-free device will deliver Scancell’s DNA immunotherapy in a Phase 3 melanoma trial. Find out what this means for the future of cancer vaccines.
Find out how Polyrizon’s NASARIX branding positions the PL-14 allergy blocker for regulatory progress and future market readiness.
CornerLoc has disclosed 6-month interim results from the ongoing SPARTAN Study evaluating its TransLoc 3D System, a lateral-oblique sacroiliac (SI) joint fusion platform. The data, published in the Pain Physician Journal, reported significant improvements in pain and function among enrolled patients, with no device-related or procedure-related adverse events during the evaluation period. The prospective multicenter
Avatar Medical is set to introduce Eonis Vision, a glasses-free 3D medical imaging system, at CES 2026. The product, developed in collaboration with Belgian display specialist Barco and powered by high-performance Dell hardware, is aimed at enhancing the clarity of doctor–patient communication. While the original Avatar Medical Vision software is already FDA-cleared, the updated version
XRlabs has disclosed it is integrating NVIDIA Jetson Thor and NVIDIA Isaac for Healthcare to develop an AI-powered retrofit system for surgical visualisation tools, aiming to deliver real-time perception, tool tracking, and intent-aware automation for neurosurgery and other minimally invasive procedures. The system is currently under early-stage clinical evaluation. Unlike traditional surgical robotics or integrated
Bracco Imaging S.p.A. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion supporting the use of Vueway gadopiclenol in pediatric patients from birth. The recommendation extends an existing European Union authorization and places the macrocyclic gadolinium-based contrast agent into one of the
Kallisio has begun clinical implementation of its FDA-cleared Stentra system at Stanford Health Care, marking the first reported integration of the patient-specific intraoral device into a major U.S. hospital’s workflow for head and neck cancer radiation therapy. The system, which received 510(k) clearance in January 2024, enables individualized immobilization of oral structures during intensity-modulated radiation
RevBio Inc. has received clearance from the United States Food and Drug Administration to begin a pilot clinical trial of TETRANITE, its regenerative bone adhesive, for dental ridge augmentation. The study will assess the product’s ability to support bone grafting procedures without the use of membranes, meshes, tacks, or screws—offering a potential simplification to a